Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide ...

MELBOURNE, Australia I April 02, 2025 I Telix Pharmaceuticals Limited (ASX: TLX; NASDAQ: TLX, Telix, the Company) today announces that a first patient has ...

"We are encouraged by the FDA's Fast Track designation for BIIB080, which highlights the urgent need for innovative ...

Telix Pharmaceuticals Limited today announces that a first patient has been dosed in the Phase 1 ZOLAR[1] trial of TLX300-CDx ...

MELBOURNE, Australia, April 02, 2025 (GLOBE NEWSWIRE) -- (ASX: TLX; NASDAQ: TLX, Telix, the Company) today announces that a first patient has been dosed in the Phase ...

Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

The new test could help identify which patients are most likely to benefit from new Alzheimer’s drugs. A newly developed ...

This issue of McDermott’s Healthcare Regulatory Check-Up highlights regulatory activity for February 2025, including long-awaited proposed and ...

A novel PET imaging approach can effectively quantify a key enzyme associated with brain inflammation, according to new ...

A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another ...

The annual incidence of cardiac sarcoidosis is low, but increased awareness of this inflammatory condition has led to earlier ...